Accueil > Revues > Biologie et recherche > Magnesium Research > Texte intégral de l'article
 
      Recherche avancée    Panier    English version 
 
Nouveautés
Catalogue/Recherche
Collections
Toutes les revues
Médecine
Biologie et recherche
Magnesium Research
- Numéro en cours
- Archives
- S'abonner
- Commander un       numéro
- Plus d'infos
Santé publique
Agronomie et Biotech.
Mon compte
Mot de passe oublié ?
Activer mon compte
S'abonner
Licences IP
- Mode d'emploi
- Demande de devis
- Contrat de licence
Commander un numéro
Articles à la carte
Newsletters
Publier chez JLE
Revues
Ouvrages
Espace annonceurs
Droits étrangers
Diffuseurs



 

Texte intégral de l'article
 
  Version imprimable
  Version PDF

The role of magnesium deficiency in cardiovascular and intestinal inflammation


Magnesium Research. Volume 23, Numéro 4, 199-206, december 2010, Short report

DOI : 10.1684/mrh.2010.0218

Summary  

Auteur(s) : William B Weglicki, Iu Tong Mak, Joanna J Chmielinska, Maria Isabel Tejero-Taldo, Andrei M. Komarov, Jay H Kramer , Division of Experimental Medicine, Departments of Biochemistry and Molecular Biology, and Medicine (Cardiology), George Washington University Medical Center, Washington DC 20037, USA.

Illustrations

ARTICLE

Auteur(s) : William B Weglicki, Iu Tong Mak, Joanna J Chmielinska, Maria Isabel Tejero-Taldo, Andrei M. Komarov, Jay H Kramer

Division of Experimental Medicine, Departments of Biochemistry and Molecular Biology, and Medicine (Cardiology), George Washington University Medical Center, Washington DC 20037, USA

Neuropeptide responses in experimental magnesium deficiency

Severe dietary Mg deficiency leads to diverse pathology in animal models: myocardial necrosis, neuromuscular hyperexcitability, arrhythmia, hyperirritability, erythema, hemorrhagic skin lesions, increased oxidative stress, and myocardial susceptibility to ischemia/reperfusion stress [1, 2] and significant systolic dysfunction [3]. Our early investigations with Mg deficient (MgD) rodents, led to the discovery that circulating levels of the pro-inflammatory neuropeptide, substance P (SP) [4, 5] were significantly elevated [6-8] within 3 days after initiating a diet (Harlan Teklad, Madison, WI) containing only 9% of Recommended Daily Allowance for Mg (100% RDA ≈ 500 mg/kg feed) [2, 9]. Calcitonin gene-related peptide was also elevated at this time, and probably emanated from sensory neuron fibers which are rich in both neuropeptides [10]. Our later studies indicated that SP may be inducing many of the inflammatory/oxidative events which eventually promote cardiomyopathy. These early and late pathological events are described in figure 1. The acute stage release of SP during Mg deficiency may initiate the events that determine the early and late stage responses. Interestingly, rats placed on moderate MgD (40% RDA) and severe MgD (9% RDA) diets for 3 weeks exhibited proportionately elevated circulating SP levels that were 2.43- and 5.14- fold higher than Mg sufficient controls (MgS ≥ 100% RDA), respectively. Indeed our findings and those of others suggested that even moderate dietary Mg deficiency induced significant systemic inflammation: increases in PGE2 [11], circulating histamine [12], and erythema [13]. In addition to the elevated levels of SP, the neurokinin-1 (NK-1) receptor for SP is increasingly expressed during Mg deficiency. Multi-label flow cytometry was used for estimation of the SP receptor in peripheral neutrophils of rats using a multi-label FACS assay with different fluorophores. The circulating neutrophils from the early stage of severe Mg deficiency indicated a 2-fold elevation of the SP receptor (figure 2). These results are consistent with our observations that superoxide production in neutrophils from MgD rats was significantly activated during the early stage of the diet. Thus, both the elevated SP levels, coupled with increased expression of the SP receptor, amplified the oxidative stress during the early stage of Mg deficiency.

N-methyl-D-aspartate (NMDA) Receptor and SP–mediated Pathobiology during Mg deficiency

The NMDA receptor/channel complex is an important mediator of neuropeptide release. The NMDA channel is blocked by Mg2+ in a voltage-dependent manner [14] and specific NMDA receptor/channel blockers are protective. For example, Dizocilpine (MK-801), a non-competitive NMDA receptor/channel blocker, prevented noise-mediated seizures [15, 16] and depressed the acoustic startle reflex [17] in MgD rats. The influence of NMDA receptor inhibition on neutrophil superoxide production in severe MgD rats was examined. The enriched blood neutrophil fractions displayed a 5.3 fold (p < 0.02) elevated basal superoxide production and pretreatment with MK-801 attenuated this superoxide response by 69%, p < 0.01 (figure 3). Neuronal localization revealed significant concentrations around blood vessels, and staining with PGP-9.5, a pan neuronal stain, demonstrated a rich perivascular innervation throughout cardiac tissue. Using serial sections to correlate neuronal regions with areas of SP distribution revealed substantial co-localization of SP and inflammation around vascular elements during Mg deficiency. The acute stage elevation in circulating SP [18] may arise, in part, from C-fibers of the dorsal root ganglia [19]. These ganglia were isolated from early stage and late stage severe MgD rats where the SP staining intensity was substantially reduced; pre-treatment of these MgD rats with MK-801 prevented much of the loss in SP staining intensity during the early and late response stages. We concluded that SP depletion from the DRG was due to unblocking of the NMDA receptor channel during Mg deficiency leading to enhanced neuronal SP release [20]. Chronic Mg deficiency also produced significant cardiac apoptosis with significantly elevated caspase 3 enzyme activity [21]. The effect of MK-801 treatment during severe Mg deficiency on DNA fragmentation in rat cardiac tissue was also examined; 33% apoptotic nuclei were seen in severe MgD hearts, and MK-801 treatment significantly decreased the number of apoptotic nuclei by 40%. Thus, cardiac apoptosis was inhibited by NMDA receptor blockade, and is likely modulated by neuronal SP release.

Neutral Endopeptidase during Mg deficiency

In addition to neuronal release of SP during the acute stage, heightened elevations of SP during the early and late response stages of Mg deficiency may also involve inactivation of neutral endopeptidase (NEP), the principal proteolytic SP-degrading enzyme [22]. Other proteases (angiotensin converting enzyme, dipeptidyl aminopeptidase IV, aminopeptidase M) may degrade SP, but only to a lesser extent [23]. NEP is a metalloprotease expressed by various tissues and cells, including heart, small intestine, kidney, brain, airway epithelium, vascular endothelium [24], neutrophils [25] and macrophages [26]. We found that NEP inactivation can lead to enhanced SP-mediated systemic inflammation during Mg deficiency [27]. Moreover, NEP can be a target of oxidative damage by circulating lipid peroxidation products (conjugated dienes, MDA-like materials) [28, 29], and during the late response stage of Mg deficiency, we showed that NEP activity was significantly depressed in circulating neutrophils (figure 4).

In additional studies we used the NEP inhibitor, phosphoramidon, to investigate its effect on circulating SP levels in conjunction with changes in oxidative stress (circulating prostaglandin E2 [PGE2], RBC glutathione [GSH] loss, and neutrophil activation). During the acute stage of Mg deficiency we found a 7.5-fold elevation in SP versus MgS control, but after phosphoramidon treatment a further 2.45-fold increase in total SP was seen versus untreated Mg deficiency (figure 5). These findings supported the notion that NEP strongly influences SP bio-availability during Mg deficiency. It remains to be determined if similar reductions in NEP activity occur in other tissues. Phosphoramidon treatment of control rats produced no significant superoxide production, indicating that, in the absence of elevated SP, the basal activity of neutrophils remained unchanged.

Intestinal inflammation in Mg deficiency

The gut is also richly innervated [32] and during Mg deficiency, the C-fibers may contribute to the early rise in plasma SP. Even during the acute stage of Mg deficiency, mucosal inflammation by neutrophils was evident, and pronounced infiltration occurred by the late response stage [33]. Our prior studies had shown elevations of TNF-α in MgD animals. Since endotoxin (lipopolysaccharide, LPS) is known to induce a systemic elevation of TNF-α [34] by stimulating cytokine secretion, we wondered whether elevated levels of LPS promoted the secretion of TNF-α in Mg deficiency. Our studies using Evan's blue dye showed a dramatic increase (19-fold > control) in capillary leak of gut tissue harvested from severe MgD rats during the early response stage [33]. Indeed, we found significantly elevated plasma LPS in the late response stage of MgD rats and these elevated levels of LPS were significantly inhibited by treatment with SP receptor blockade (figure 6). We reported previously that in vivo SP receptor blockade (CP-96,345) in MgD rats significantly lowered plasma TNF-α levels during the early response stage [6]. Taken together, these findings indicate a role for SP in the elevations of both LPS and TNF-α during Mg deficiency.

Since endotoxin receptor (CD14) is known to be up-regulated in cells exposed to LPS, we used immunohistochemical staining to monitor the expression of this LPS receptor [35,36]. We found prominent CD14 positive macrophage-type cells in the intestine of severe MgD rats during the early response stage; we also observed enhanced CD14 receptor expression in the cardiac tissue. The importance of CD14 in LPS-induced responses was shown previously using transgenic mice over-expressing CD14 receptor [37], where the known cardio-depressant effects of LPS were dependent on this CD14 signaling [38]. These observed significant elevations in plasma LPS in MgD rats indicated that prolonged Mg deficiency results in increased intestinal permeability to bacterial products leading to increased circulating LPS, along with elevated endotoxin receptor expression in the heart; this CD14 elevation may further amplify the cardiomyopathy leading to eventual contractile dysfunction. Recently, we used trans-thoracic echocardiography to study cardiac contractility during severe Mg deficiency in rats. We found that significantly impaired diastolic function occurred during the early response stage, and systolic function (% ejection fraction) was significantly decreased during the late response stage [3]. We anticipate that prolonged exposure (> 7 weeks) to a moderate MgD diet will also lead to impaired cardiac function, based on our observations of depressed baseline contractility in perfused hearts from these animals [3].

In conclusion, the animal studies of dietary Mg deficiency indicate that an inflammatory process is triggered by neuronal release of SP which may affect cardiovascular and intestinal tissues. In the event that gut permeability is enhanced, endotoxemia may result in further systemic inflammatory responses. The clinical literature has documented that patients with congestive heart failure may have elevated endotoxin levels [39-40] and that hypomagnesemia [41] may also be present due to diuretic therapy and other concurrent disease processes. We suggest that some of the findings from animal studies of Mg deficiency may have some clinically relevant parallels and we submit that the careful assessment of Mg status in patients may indicate the need for more frequent oral and intravenous therapy with this important electrolyte.Financial support and disclosure

Supported by NIH Grants: RO1 HL062282 and HL 065178.

None of the authors has any conflict of interest to disclose.

References

1 Kramer JH, Phillips TM, Weglicki WB. Magnesium-deficiency enhanced postischemic myocardial injury is reduced by substance P receptor blockade. J Mol Cell Cardiol 1997; 29: 97-110.

2 Kramer JH, Mak IT, Phillips TM, Weglicki WB. Dietary Mg-intake influence circulating pro-inflammatory neuropeptide levels and loss of myocardial tolerance to postischemic stress. Exp Biol Med 2003; 228: 665-73.

3 Kramer JH, Spurney C, Iantorno M, Tziros C, Mak IT, Tejero-Taldo MI, Chmielinska JJ, Komarov AM, Weglicki WB. Neurogenic inflammation and cardiac dysfunction due to hypomagnesemia. Am J Med Sci 2009; 338: 22-7.

4 Mantyh PW. Substance P and the inflammatory and immune response. Ann NY Acad Sci 1991; 632: 263-71.

5 Bost KL, Pascual DW. Substance P. A late-acting B lymphocyte differentiation cofactor. Am J Physiol Cell Physiol 1992; 262: C537-CC45.

6 Weglicki WB, Mak IT, Stafford RE, Dickens BF, Cassidy MM, Phillips TM. Neurogenic peptides and the cardiomyopathy of Mg-deficiency: Effects of substance P-receptor inhibition. Mol Cell Biochem 1994; 130: 103-9.

7 Weglicki WB, Phillips TM. Pathobiology of magnesium deficiency: a cytokine/neurogenic inflammation hypothesis. Am J Physiol 1992; 263: R734-R7R7.

8 Weglicki WB, Mak IT, Phillips TM. Blockade of cardiac inflammation in Mg-deficiency by substance P receptor inhibition. Circ Res 1994; 24: 1009-13.

9 Reeves PG, Nielsen FH, Fahey Jr GC. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993; 123: 1939-51.

10 Furness JB, Costa M, Papka RE, Della NG, Murphy R. Neuropeptides contained in peripheral cardiovascular nerves. Clin Exp Hypertens [A] 1984; 6: 91-106.

11 Soma M, Cunnane SC, Horrobin DF, Manku MS, Honda M, Hatano M. Effects of low magnesium diet on the vascular prostaglandin and fatty acid metabolism in rats. Prostaglandins 1988; 36: 431-41.

12 Kraeuter SL, Schwartz R. Blood and mast cell histamine levels in magnesium-deficient rats. J Nutr 1980; 110: 851-8.

13 Classen CU, Abele C, Schimatschek HF, Friedberg KD, Classen HG, Haubold W. Erythema formation in magnesium-deficient albino rats. A non-invasive model for screening anti-inflammatory agents and oral mineral supplements. Arzneimittelforschung 1993; 43: 672-5.

14 McIntosh TK. Novel pharmacologic therapies in the treatment of experimental traumatic brain injury: a review. J Neurotrauma 1993; 10: 215-61.

15 Pierson M, Swann J. Sensitization to noise-mediated induction of seizure susceptibility by MK-801 and phencyclidine. Brain Res 1991; 560: 229-36.

16 Nakamura M. Cardiac arrhythmias in magnesium deficiency. In: Theophanides T, Anastassopoulou J, eds. Magnesium: Current Status and New Developments. Theoretical, Biological and Medical Aspects. Dordrecht, Netherlands: Kluwer Academic Publishers, 1997: 215-21.

17 Miserendino MJ, Davis M. NMDA and non-NMDA antagonists infused into the nucleus reticularis pontis caudalis depress the acoustic startle reflex. Brain Res 1993; 623: 215-22.

18 Mak IT, Kramer JH, Chmielinska JJ, Khalid H, Landgraf K, Weglicki WB. Inhibition of Neutral endopeptidase potentiates neutrophil activation during Mg-deficiency in the rat. Inflamm Res 2008; 57: 300-5.

19 Leeman SE. Substance P and neurotensin: discovery, isolation, chemical characterization and physiological studies. J Exp Biol 1980; 89: 193-200.

20 Tejero-Taldo MI, Chmielinska JJ, Gonzalez G, Mak IT, Weglicki WB. N-Methyl D- Aspartate Receptor Blockade Inhibits Cardiac Inflammation in the Mg2+ - Deficient Rat. JPET 2004; 311: 8-13.

21 Tejero-Taldo MI, Chmielinska JJ, Weglicki WB. Chronic dietary Mg2+ deficiency induces cardiac apoptosis in the rat heart. Magnes Res 2007; 20: 208-12.

22 Scholzen TE, Steinhoff M, Bonaccorsi P, Klein R, Amadesi S, Geppetti B, Lu B, Gerard NP, Olerud JE, Luger TA, Bunnett NW, Grady EF, Armstrong CA, Ansel JC. Neutral endopeptidase terminates substance-P induced inflammation in allergic contact dermatitis. J Immunol 2001; 166: 1285-91.

23 Wang L, Sadoun E, Stephens RE, Ward PE. Metabolism of substance P and neurokinin A by human vascular endothelium and smooth muscle. Peptides 1994; 15: 497-503.

24 Nadel JA. Peptidase modulation of neurogenic inflammation (P Geppetti and P. Holzer eds). Neurogenic inflammation. CRC Press 1996; 115-27.

25 Iwamoto I, Kimura A, Ochiai K, Tomioka H, Yoshida S. Distribution of NEP activity in human blood leukocytes. J Leuk Biol 1991; 49: 116-25.

26 Lesser M, Fung K, Choi HS, Yoo OH, Cardozo C. Identification of two zinc metalloendopeptidases in alveolar macrophages of rats, guinea pigs, and human beings. J Lab Clin Med 1992; 120: 597-603.

27 Weglicki WB, Chmielinska JJ, Tejero-Taldo MI, Kramer JH, Spurney C, Viswalingham K, Lu B, Mak IT. Neutral endopeptidase inhibition enhances substance P mediated inflammation due to hypomagnesemia. Magnes Res 2009; 22: 167-73.

28 Lauderback CM, Hackett JM, Huang FF, Keller JN, Szweda LI, Butterfield DA. The glial glutamate transporter, GLT-1 is oxidatively modified by 4-HNA in the Alzheimer disease brain: the role of Abeta 1. J Neutrochem 2001; 78: 413-6.

29 Wang DS, Iwata N, Hama E, Saido TC, Dickson DW. Oxidized neprilysin in aging and Alzheimer's disease brains. Biochemical and Biophysical Res Communications 2003; 310: 236.

30 Miners JS, Van Helmond Z, Chalmers K, Wilcock G, Love S, Kehoe PG. Decreased Expression and Activity of Neprilysin in Alzheimer Disease are Associated with Cerebral Amyloid Angiopathy. J Neuropathol Exp Neurol 2006; 65: 1012-21.

31 Substance P Assay. R&D Systems Catalog # KGE007 User Manual (Minneapolis, MN). 2007.

32 Zhou M, Arthur AJ, Ba ZF, Chaudry IH, Wang P. The small intestine plays an important role in upregulating CGRP during sepsis. Am J Physiol Regul Integr Comp Physiol 2001; 280: R382-R388.

33 Scanlan BJ, Kim SY, Tuft B, Elfrey JE, Smith A, Zhao A, Morimoto M, Chmielinska JJ, Tejero-Taldo MI, Mak IT, Weglicki WB, Shea-Donohue T. Intestinal inflammation caused by magnesium deficiency alters basal and oxidative stress-induced intestinal function. Mol Cell Biochem 2007; 306: 56-9.

34 Malpuech-Brugère C, Nowacki W, Rock E, Gueux E, Mazur A, Rayssiguier Y. Enhanced tumor necrosis factor-alpha production following endotoxin challenge in rats is an early event during magnesium deficiency. Biochim Biophys Acta 1999; 1453: 35-40.

35 Opal SM, Scannon PJ, Vincent JL, White M, Carroll SF, Palardy JE, Parejo NA, Pribble JP, Lemke JH. Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Diseases 1999; 180: 1584-9.

36 Chmielinska JJ, Tejero-Taldo MI, Mak IT, Weglicki WB. Intestinal and cardiac inflammatory response shows enhanced endotoxin receptor (CD14) expression in magnesium deficiency. Mol Cell Biochem 2005; 278: 53-7.

37 Ferrero E, Jiao D, Tsuberi BZ, Tesio L, Rong GW, Haziot A, Goyert SM. Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide. Proc Natl Acad Sci USA 1993; 90: 2380-4.

38 Comstock KL, Krown KA, Page MT, Martin D, Ho P, Pedraza M, Castro EN, Nakajima N, Glembotski CC, Quintana PJ, Sabbadini RA. LPS-induced TNF-alpha release from and apoptosis in rat cardiomyocytes: obligatory role for CD14 in mediating the LPS response. J Mol Cell Cardiol 1998; 30: 2761-75.

39 Peschel T, Schönauer M, Thiele H, Anker S, Schuler G, Niebauer J. Invasive assessment of bacterial endotoxin and inflammatory cytokines in patients with acute heart failure. Eur J Heart Failure 2003; 5: 609-14.

40 Bolger AP, Anker SD. Tumour necrosis factor in chronic heart failure: a peripheral view on pathogenesis, clinical manifestations and therapeutic implications. Drugs 2000; 60: 1245-57.

41 Liebscher DH, Liebscher DE. About the misdiagnosis of magnesium deficiency. J Am Coll Nutr 2004; 23: 730S-731S.


 

Qui sommes-nous ? - Contactez-nous - Conditions d'utilisation - Paiement sécurisé
Actualités - Les congrès
Copyright © 2007 John Libbey Eurotext - Tous droits réservés
[ Informations légales - Powered by Dolomède ]